Desq Long
Sign in
SEC FORM 4
$1,573,075.00

Spyre Therapeutics, Inc. (SYRE)

Sale of 17,500 shares at $89.89 per share.

Reporting Person Burrows Scott L · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001636282-26-000117 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Spyre Therapeutics, Inc. (SYRE)." Disclosed 2026-10-02. https://desqlong.com/cards/0001636282-26-000117-2 (retrieved 2026-10-03).